Gastroparesis in Cystic Fibrosis - Trial NCT05223881
Access comprehensive clinical trial information for NCT05223881 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Miami and is currently Withdrawn. The study focuses on Gastroparesis. Target enrollment is 0 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Miami
Timeline & Enrollment
N/A
Feb 14, 2022
Mar 30, 2023
Primary Outcome
Rate of gastric emptying
Summary
The purpose of this research is to determine if an investigational device called the
 13C-Spirulina Gastric Emptying Breath Test (GEBT), can accurately diagnose gastroparesis
 (delayed emptying of the stomach) in patients with Cystic Fibrosis (CF).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05223881
Device Trial